Table 2.
Multivariable logistic regression analysis of associated factors with access to smoking cessation clinics. Multicenter, prospective, randomized, open-label study, conducted between November 2022 and June 2023 at pulmonary outpatient clinics in Türkiye (N=397)
| Variables | β | AOR* | 95% CI | p |
|---|---|---|---|---|
| Randomization arm | ||||
| Usual support | Ref. | |||
| Immediate support | 2.594 | 13.38 | 8.00–22.38 | <0.001 |
| Age (years) (per 1 unit age increase) | 0.015 | 1.02 | 0.96–1.08 | 0.624 |
| Presence of comorbidity | ||||
| Present | Ref. | |||
| Absent | 0.302 | 1.35 | 0.76–2.41 | 0.305 |
| Duration of smoking (years) (per 1 year increase) | -0.037 | 0.96 | 0.91–1.02 | 0.209 |
| Initiation age of smoking (years) (per 1 year increase) | -0.026 | 0.975 | 0.91–1.04 | 0.460 |
| Anxiety disorder | ||||
| Present | Ref. | |||
| Absent | -0.439 | 0.64 | 0.33–1.28 | 0.207 |
AOR: adjusted odds ratio. FEV1: forced expiratory volume in 1st second.
*
Model is adjusted for income level, FEV1%, Fagerström test score, types of airway diseases, and education level.